Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Disease, Interstitial”

1,761 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,761 results

Not applicableLooking for participantsNCT05310669
What this trial is testing

Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Fibrosis, Pulmonary
University of Modena and Reggio Emilia 100
Not applicableStudy completedNCT01789996
What this trial is testing

The Six Minute Walk Test: Influence of Instruction on Results

Who this might be right for
Interstitial Lung Disease
Inova Health Care Services 45
Not applicableEnded earlyNCT05267418
What this trial is testing

Effects of Automated Oxygen Titration Alone or With High Flow Nasal Therapy on Dyspnea and Exercise Tolerance

Who this might be right for
DyspneaLung DiseasesPulmonary Hypertension+3 more
Laval University 30
Testing effectiveness (Phase 2)Study completedNCT03215927
What this trial is testing

Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease

Who this might be right for
MyositisInterstitial Lung Disease
Rohit Aggarwal, MD 20
Not applicableStudy completedNCT03300583
What this trial is testing

Toward Self-management in ILD

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisConnective Tissue Related ILD+2 more
Kingston University 16
Not applicableUnknownNCT02826265
What this trial is testing

Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary DiseaseBronchial AsthmaInterstitial Lung Disease
Universitätsmedizin Mannheim 100
Testing effectiveness (Phase 2)UnknownNCT02809456
What this trial is testing

Mitigation of Radiation Pneumonitis, Fibrosis and Heart Toxicity With Nicorandil in Lung Cancer Patients

Who this might be right for
Radiation Pneumonitis
Taipei Medical University WanFang Hospital 50
Not applicableUnknownNCT04320667
What this trial is testing

Urinary T Cell Biomarker for Prediction in ANCA Glomerulonephritis

Who this might be right for
Glomerulonephritis Acute
Charite University, Berlin, Germany 79
Large-scale testing (Phase 3)Study completedNCT06383819
What this trial is testing

Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19

Who this might be right for
Post-Acute COVID-19 SyndromeLung Disease With PolymyositisFibrosis+2 more
NPO Petrovax 392
Testing effectiveness (Phase 2)Looking for participantsNCT07473700
What this trial is testing

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

Who this might be right for
Hypertension, PulmonaryLung Diseases, Interstitial
Tectonic Operating Company, Inc. 25
Large-scale testing (Phase 3)Looking for participantsNCT02670707
What this trial is testing

Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

Who this might be right for
Langerhans Cell Histiocytosis
Baylor College of Medicine 124
Testing effectiveness (Phase 2)Study completedNCT01417156
What this trial is testing

Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 20
Not applicableStudy completedNCT03944928
What this trial is testing

ThOracic Ultrasound in Idiopathic Pulmonary Fibrosis Evolution

Who this might be right for
Idiopathic Pulmonary Fibrosis
University Hospital, Tours 30
Testing effectiveness (Phase 2)UnknownNCT05118256
What this trial is testing

Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated Silicosis

Who this might be right for
SilicosisProgressive Massive FibrosisComplicated Silicosis
Instituto de investigación e innovación biomédica de Cádiz 18
Not applicableNot Yet RecruitingNCT06852794
What this trial is testing

USE OF ARTIFICIAL INTELLIGENCE IN A PULMONARY FIBROSIS CLINIC

Who this might be right for
Interstitial Disease
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Not applicableStudy completedNCT02044939
What this trial is testing

Pulmonary Rehabilitation in Patients With Sarcoidosis

Who this might be right for
Stage 4 Pulmonary Sarcoidosis
University Hospital, Lille 38
Not applicableEnded earlyNCT02821039
What this trial is testing

Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study

Who this might be right for
Idiopathic Pulmonary FibrosisUsual Interstitial Pneumonia
Turkish Thoracic Society 1,678
Not applicableNot Yet RecruitingNCT07205627
What this trial is testing

Evaluation of the Diaphragmatic Index Before and After a Pulmonary Rehabilitation Program in Patients With Interstitial Lung Diseases and Its Impact on Quality of Life

Who this might be right for
Lung Disease Interstitial Diffuse
Hospital Civil de Guadalajara 20
Post-approval studies (Phase 4)UnknownNCT05284942
What this trial is testing

Central China Rosai-Dorfman Disease Registry

Who this might be right for
Rosai-Dorfman DiseaseLangerhans Cell Histiocytosis
Tongji Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Next Page